Results 11 to 20 of about 297,361 (266)
Thoracic Cancer, 2020 Immune checkpoint inhibitors (ICIs) can cause adverse reactions in the nervous system. The incidence rate is 0.1%–12% and 80% of nervous system adverse reactions occur within the first four months of application.
Jiayu Shi +9 more
doaj +1 more source
Autoimmune Disorders of the Nervous System: Pathophysiology, Clinical Features, and Therapy
Frontiers in Neurology, 2021 Remarkable discoveries over the last two decades have elucidated the autoimmune basis of several, previously poorly understood, neurological disorders.
Satyakam Bhagavati
doaj +1 more source
Neurological Diseases: Cause and Effect in the Era of COVID-19
SVU - International Journal of Medical Sciences, 2021 Background: SARS-CoV-2 new infectious disease was first reported in Wuhan, China in December 2019. Thereafter, it has extensively spread causing global pandemic. It was named as corona virus disease 2019 (COVID-19) by WHO in February 2020. Other than the
Islam Elmalky * +2 more
doaj +1 more source
Impairment of the Peripheral Nervous System in Creutzfeldt-Jakob Disease [PDF]
Archives of Neurology, 2002 The clinical manifestations of Creutzfeldt-Jakob disease (CJD) primarily reflect involvement of the central nervous system. The coexistence of CJD with peripheral nervous system involvement has also been reported.To analyze peripheral neuron electrophysiologic changes and to compare these data with neuropathologic features of spinal motor neurons in ...
M. Niewiadomska +10 more
openaire +3 more sources
Progress in HIV⁃related nervous system diseases
Chinese Journal of Contemporary Neurology and Neurosurgery, 2021 Since combination antiretroviral therapy (cART) appeared, the epidemiology and spectrum of human immunodeficiency virus (HIV)⁃related nervous system diseases have changed significantly.
DAI Fei⁃fei , WANG Jia⁃wei
doaj +1 more source
Value of Neurofilament Light Chain as a Biomarker in Peripheral Neuropathy [PDF]
Zhongguo quanke yixue, 2022 Neurofilament light chain (NfL) has been identified as a biomarker of axonal injury in a variety of central nervous system diseases. The value of NfL as a biomarker in peripheral neuropathy has gained increasing attention.
SUN Xiaoling, HUANG Kaiwei, WAN Xinbei, WU Ying, LI Zhijun
doaj +1 more source
Peripheral nervous system diseases and pregnancy
Journal of obstetrics and women's diseases, 1999 113 pregnant women with periferal nervous system diseases(PNSD) are examined. 84 of them had radiculoneuropathy: 48 - lumbosacral segment (LSS), 36 - cervicothoracal segment (CTS), 29 had single and multiple neuropathy (SMN). Almost half cases (49,6%) the symptoms of PNSD first appeared in 2nd trimester.
V. D. Ryzkov +2 more
openaire +3 more sources
Peripherin is a biomarker of axonal damage in peripheral nervous system disease
Brain, 2023 Abstract Valid, responsive blood biomarkers specific to peripheral nerve damage would improve management of peripheral nervous system (PNS) diseases. Neurofilament light chain (NfL) is sensitive for detecting axonal pathology but is not specific to PNS damage, as it is expressed throughout the PNS and CNS.
Keddie, S +15 more
openaire +4 more sources
Bidirectional crosstalk between the peripheral nervous system and lymphoid tissues/organs
Frontiers in Immunology, 2023 The central nervous system (CNS) influences the immune system generally by regulating the systemic concentration of humoral substances (e.g., cortisol and epinephrine), whereas the peripheral nervous system (PNS) communicates specifically with the immune
Angela Boahen +5 more
doaj +1 more source
Focus on 1,25-Dihydroxyvitamin D3 in the Peripheral Nervous System
Frontiers in Neuroscience, 2019 In this review, we draw attention to the roles of calcitriol (1,25-dihydroxyvitamin D3) in the trophicity of the peripheral nervous system. Calcitriol has long been known to be crucial in phosphocalcium homeostasis. However, recent discoveries concerning
Pierre Antoine Faye +11 more
doaj +1 more source